This report describes and explains the clinical decision support systems market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global clinical decision support systems market reached a value of nearly $3.14 billion in 2024, having grown at a compound annual growth rate (CAGR) of 13.28% since 2019. The market is expected to grow from $3.14 billion in 2024 to $5.75 billion in 2029 at a rate of 12.86%. The market is then expected to grow at a CAGR of 13.31% from 2029 and reach $10.74 billion in 2034.
Growth in the historic period resulted from the rising demand for personalized medicine, increase in the adoption of information systems by hospitals, adoption of electronic health records (EHRs) and expansion of telemedicine. Factors that negatively affected growth in the historic period were lack of standardization and limited reimbursement policies.
Going forward, the rising demand for cloud computing, shortage of skilled healthcare professionals, increasing incidence of medical errors and favorable government initiatives will drive the growth. Factor that could hinder the growth of the clinical decision support systems market in the future include healthcare data breaches and regulatory and legal barriers.
North America was the largest region in the clinical decision support systems market, accounting for 42.65% or $1.34 billion of the total in 2024. It was followed by Asia-Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the clinical decision support systems market will be Asia-Pacific and Africa where growth will be at CAGRs of 16.06% and 14.54% respectively. These will be followed by Middle East and Eastern Europe where the markets are expected to grow at CAGRs of 14.21% and 13.31% respectively.
The global clinical decision support systems market is highly concentrated, with large players operating in the market. The top ten competitors in the market made up to 76.23% of the total market in 2023. Epic Systems Corporation was the largest competitor with a 15.75% share of the market, followed by Oracle Corporation with 11.91%, Medical Information Technology, Inc. (Meditech) with 8.88%, UnitedHealth Group. (Change Healthcare Inc.) with 7.61%, Athenahealth Inc with 7.49%, Siemens Healthineers GmbH with 6.95%, Wolters Kluwer NV with 6.59%, Altera Digital Health with 5.50%, MEDHOST with 2.83% and TruBridge with 2.73%.
The clinical decision support systems market is segmented by component into services, software and hardware. The services market was the largest segment of the clinical decision support systems market segmented by component, accounting for 45.22% or $1.42 billion of the total in 2024. Going forward, the software segment is expected to be the fastest growing segment in the clinical decision support systems market segmented by component, at a CAGR of 14.77% during 2024-2029.
The clinical decision support systems market is segmented by model into knowledge-based CDSS and non-knowledge CDSS. The knowledge-based CDSS market was the largest segment of the clinical decision support systems market segmented by model, accounting for 60.11% or $1.88 billion of the total in 2024. Going forward, the knowledge-based CDSS segment is expected to be the fastest growing segment in the clinical decision support systems market segmented by model, at a CAGR of 13.58% during 2024-2029.
The clinical decision support systems market is segmented by application into medical diagnosis, alerts and reminders, prescription decision support, information retrieval and other applications. The medical diagnosis market was the largest segment of the clinical decision support systems market segmented by application, accounting for 30.14% or $947.22 million of the total in 2024. Going forward, the medical diagnosis segment is expected to be the fastest growing segment in the clinical decision support systems market segmented by application, at a CAGR of 13.74% during 2024-2029.
The clinical decision support systems market is segmented by end-user into clinics, hospitals, ambulatory surgical centers, general practitioners, psychiatrists and other end users. The hospitals market was the largest segment of the clinical decision support systems market segmented by end-user, accounting for 35.82% or $1.12 billion of the total in 2024. Going forward, the clinics segment is expected to be the fastest growing segment in the clinical decision support systems market segmented by end-user, at a CAGR of 14.33% during 2024-2029.
The clinical decision support systems market is segmented by delivery mode into on-premise and cloud-based. The on-premise market was the largest segment of the clinical decision support systems market segmented by delivery mode, accounting for 55.80% or $1.75 billion of the total in 2024. Going forward, the cloud-based segment is expected to be the fastest growing segment in the clinical decision support systems market segmented by delivery mode, at a CAGR of 17.96% during 2024-2029.
The top opportunities in the clinical decision support systems market segmented by component will arise in the services segment, which will gain $1.12 billions of global annual sales by 2029. The top opportunities in the clinical decision support systems market segmented by model will arise in the knowledge-based CDSS segment, which will gain $1.68 billions of global annual sales by 2029. The top opportunities in the clinical decision support systems market segmented by delivery mode will arise in the cloud-based segment, which will gain $1.78 billions of global annual sales by 2029. The top opportunities in the clinical decision support systems market segmented by application will arise in the medical diagnosis segment, which will gain $855.76 millions of global annual sales by 2029. The top opportunities in the clinical decision support systems market segmented by end-user will arise in the hospitals segment, which will gain $938.0 millions of global annual sales by 2029. The clinical decision support systems market size will gain the most in the USA at $883.01 million.
Market-trend-based strategies for the clinical decision support systems market include focus on strategic partnerships driving innovation in clinical decision support systems, focus on integration of generative AI in clinical decision support systems, focus on empowering healthcare professionals with AI-driven clinical intelligence, focus on optimizing cardiovascular care with digital CDS innovations, focus on advancements in cloud-based clinical decision support for personalized insulin dosing and focus on AI-powered diagnostics enhancing mobile clinical decision support.
Player-adopted strategies in the clinical decision support systems market include focus on expanding business capabilities through new product launch and focus on expanding manufacturing capabilities through strategic investment.
To take advantage of the opportunities, the analyst recommends the clinical decision support system to focus on integrating generative AI to enhance clinical decision support, focus on developing AI-powered clinical decision support tools, focus on advancing AI-powered clinical decision support solutions, focus on developing cloud-based, FDA-cleared insulin dosing platforms, focus on enhancing mobile apps with AI-powered features for clinical decision support, focus on the software segment for faster growth, focus on the knowledge-based CDSS segment for sustained growth, focus on the knowledge-based CDSS segment for sustained growth, expand in emerging markets, focus on strategic partnerships for innovation and growth, focus on pricing flexibility and value-based models, enhance digital marketing and targeted advertising, build strong relationships with key opinion leaders and healthcare organizations, focus on medical diagnosis segment for growth and focus on clinics market for growth.
The global clinical decision support systems market reached a value of nearly $3.14 billion in 2024, having grown at a compound annual growth rate (CAGR) of 13.28% since 2019. The market is expected to grow from $3.14 billion in 2024 to $5.75 billion in 2029 at a rate of 12.86%. The market is then expected to grow at a CAGR of 13.31% from 2029 and reach $10.74 billion in 2034.
Growth in the historic period resulted from the rising demand for personalized medicine, increase in the adoption of information systems by hospitals, adoption of electronic health records (EHRs) and expansion of telemedicine. Factors that negatively affected growth in the historic period were lack of standardization and limited reimbursement policies.
Going forward, the rising demand for cloud computing, shortage of skilled healthcare professionals, increasing incidence of medical errors and favorable government initiatives will drive the growth. Factor that could hinder the growth of the clinical decision support systems market in the future include healthcare data breaches and regulatory and legal barriers.
North America was the largest region in the clinical decision support systems market, accounting for 42.65% or $1.34 billion of the total in 2024. It was followed by Asia-Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the clinical decision support systems market will be Asia-Pacific and Africa where growth will be at CAGRs of 16.06% and 14.54% respectively. These will be followed by Middle East and Eastern Europe where the markets are expected to grow at CAGRs of 14.21% and 13.31% respectively.
The global clinical decision support systems market is highly concentrated, with large players operating in the market. The top ten competitors in the market made up to 76.23% of the total market in 2023. Epic Systems Corporation was the largest competitor with a 15.75% share of the market, followed by Oracle Corporation with 11.91%, Medical Information Technology, Inc. (Meditech) with 8.88%, UnitedHealth Group. (Change Healthcare Inc.) with 7.61%, Athenahealth Inc with 7.49%, Siemens Healthineers GmbH with 6.95%, Wolters Kluwer NV with 6.59%, Altera Digital Health with 5.50%, MEDHOST with 2.83% and TruBridge with 2.73%.
The clinical decision support systems market is segmented by component into services, software and hardware. The services market was the largest segment of the clinical decision support systems market segmented by component, accounting for 45.22% or $1.42 billion of the total in 2024. Going forward, the software segment is expected to be the fastest growing segment in the clinical decision support systems market segmented by component, at a CAGR of 14.77% during 2024-2029.
The clinical decision support systems market is segmented by model into knowledge-based CDSS and non-knowledge CDSS. The knowledge-based CDSS market was the largest segment of the clinical decision support systems market segmented by model, accounting for 60.11% or $1.88 billion of the total in 2024. Going forward, the knowledge-based CDSS segment is expected to be the fastest growing segment in the clinical decision support systems market segmented by model, at a CAGR of 13.58% during 2024-2029.
The clinical decision support systems market is segmented by application into medical diagnosis, alerts and reminders, prescription decision support, information retrieval and other applications. The medical diagnosis market was the largest segment of the clinical decision support systems market segmented by application, accounting for 30.14% or $947.22 million of the total in 2024. Going forward, the medical diagnosis segment is expected to be the fastest growing segment in the clinical decision support systems market segmented by application, at a CAGR of 13.74% during 2024-2029.
The clinical decision support systems market is segmented by end-user into clinics, hospitals, ambulatory surgical centers, general practitioners, psychiatrists and other end users. The hospitals market was the largest segment of the clinical decision support systems market segmented by end-user, accounting for 35.82% or $1.12 billion of the total in 2024. Going forward, the clinics segment is expected to be the fastest growing segment in the clinical decision support systems market segmented by end-user, at a CAGR of 14.33% during 2024-2029.
The clinical decision support systems market is segmented by delivery mode into on-premise and cloud-based. The on-premise market was the largest segment of the clinical decision support systems market segmented by delivery mode, accounting for 55.80% or $1.75 billion of the total in 2024. Going forward, the cloud-based segment is expected to be the fastest growing segment in the clinical decision support systems market segmented by delivery mode, at a CAGR of 17.96% during 2024-2029.
The top opportunities in the clinical decision support systems market segmented by component will arise in the services segment, which will gain $1.12 billions of global annual sales by 2029. The top opportunities in the clinical decision support systems market segmented by model will arise in the knowledge-based CDSS segment, which will gain $1.68 billions of global annual sales by 2029. The top opportunities in the clinical decision support systems market segmented by delivery mode will arise in the cloud-based segment, which will gain $1.78 billions of global annual sales by 2029. The top opportunities in the clinical decision support systems market segmented by application will arise in the medical diagnosis segment, which will gain $855.76 millions of global annual sales by 2029. The top opportunities in the clinical decision support systems market segmented by end-user will arise in the hospitals segment, which will gain $938.0 millions of global annual sales by 2029. The clinical decision support systems market size will gain the most in the USA at $883.01 million.
Market-trend-based strategies for the clinical decision support systems market include focus on strategic partnerships driving innovation in clinical decision support systems, focus on integration of generative AI in clinical decision support systems, focus on empowering healthcare professionals with AI-driven clinical intelligence, focus on optimizing cardiovascular care with digital CDS innovations, focus on advancements in cloud-based clinical decision support for personalized insulin dosing and focus on AI-powered diagnostics enhancing mobile clinical decision support.
Player-adopted strategies in the clinical decision support systems market include focus on expanding business capabilities through new product launch and focus on expanding manufacturing capabilities through strategic investment.
To take advantage of the opportunities, the analyst recommends the clinical decision support system to focus on integrating generative AI to enhance clinical decision support, focus on developing AI-powered clinical decision support tools, focus on advancing AI-powered clinical decision support solutions, focus on developing cloud-based, FDA-cleared insulin dosing platforms, focus on enhancing mobile apps with AI-powered features for clinical decision support, focus on the software segment for faster growth, focus on the knowledge-based CDSS segment for sustained growth, focus on the knowledge-based CDSS segment for sustained growth, expand in emerging markets, focus on strategic partnerships for innovation and growth, focus on pricing flexibility and value-based models, enhance digital marketing and targeted advertising, build strong relationships with key opinion leaders and healthcare organizations, focus on medical diagnosis segment for growth and focus on clinics market for growth.
Major Market Trends
- Strategic Partnerships Driving Innovation in Clinical Decision Support Systems
- Integration of Generative AI in Clinical Decision Support Systems
- Empowering Healthcare Professionals With AI-Driven Clinical Intelligence
- Optimizing Cardiovascular Care With Digital CDS Innovations
- Advancements in Cloud-Based Clinical Decision Support for Personalized Insulin Dosing
- AI-Powered Diagnostics Enhancing Mobile Clinical Decision Support
Key Mergers and Acquisitions
- AirStrip Technologies Acquired DECISIO Health
- VitalHub Acquired MedCurrent Corporation
- Beckman Coulter Diagnostics Acquired StoCastic
- Dedalus Group Acquired ExpertDoc
- Amalgam Acquired Avhana Health
Table of Contents
1 Executive Summary
6 Market Characteristics
7 Major Market Trends
8 Global Clinical Decision Support Systems Growth Analysis and Strategic Analysis Framework
9 Global Clinical Decision Support Systems Market Segmentation
10 Clinical Decision Support Systems Market, Regional and Country Analysis
11 Asia-Pacific Market
12 Western Europe Market
13 Eastern Europe Market
14 North America Market
15 South America Market
16 Middle East Market
17 Africa Market
18 Competitive Landscape and Company Profiles
19 Other Major and Innovative Companies
22 Key Mergers and Acquisitions
23 Recent Developments in the Clinical Decision Support Systems market
24 Opportunities and Strategies
25 Clinical Decision Support Systems Market, Conclusions and Recommendations
26 Appendix
Executive Summary
Clinical Decision Support System Global Market Opportunities and Strategies to 2034 provides the strategists; marketers and senior management with the critical information they need to assess the global clinical decision support System market.Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Description
Where is the largest and fastest-growing market for clinical decision support clinical decision support? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The clinical decision support market global report answers all these questions and many more.The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider clinical decision support system market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by component, by model, by delivery mode, by application and by end-user.
- Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Growth Analysis and Strategic Analysis Framework - Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
- Global Market Size and Growth - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional and Country Analysis - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
- Market Segmentation - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by component, by model, by delivery mode, by application and by end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
- Regional Market Size and Growth - Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Other Major and Innovative Companies - Details on the company profiles of other major and innovative companies in the market.
- Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
- Competitive Dashboard - Briefs on competitive dashboard of major players.
- Key Mergers and Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
- Recent Developments - Information on recent developments in the market covered in the report.
- Market Opportunities and Strategies Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions and Recommendations This section includes recommendations for clinical decision support system providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
1) by Component: Services; Software; Hardware2) by Model: Knowledge-Based CDSS; Non-Knowledge-Based CDSS
3) by Delivery Mode: on-Permise; Cloud-Based
4) by Application: Medical Diagnosis; Alerts and Reminders; Prescription Decision Support; Information Retrieval; Clinical Practice Guidelines; Other Applications
5) by End-User: Clinics; Hospitals; Ambulatory Surgical Centers; General Practitioners; Psychiatrists; Other End Users
Key Companies Profiled: Epic Systems Corporation; Oracle Corporation; Medical Information Technology, Inc. (Meditech); UnitedHealth Group. (Change Healthcare Inc.); Athenahealth Inc.
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; clinical decision support system indicators comparison.
Data Segmentation: Country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Companies Mentioned
The companies featured in this Clinical Decision Support System market report include:- Epic Systems Corporation
- Oracle Corporation
- Medical Information Technology, Inc. (Meditech)
- UnitedHealth Group. (Change Healthcare Inc.)
- Athenahealth Inc.
- Siemens Healthineers GmbH
- Wolters Kluwer N.V.
- Altera Digital Health
- MEDHOST
- TruBridge
- Lunit
- VUNO
- Deepnoid
- Samsung SDS
- NEC Corporation,
- M3 Inc
- Neusoft Medical Systems
- Ping An Healthcare and Technology
- Shukun Technology
- Fujitsu Limited
- Apollo Hospitals
- DocMode Health Technologie
- AffaMed Therapeutics
- Elsevier Health, ICON plc
- Eurofins Scientific SE
- Asseco Medical Solutions
- Comarch Healthcare
- InterSystems
- VitalHub Corp
- GE HealthCare
- Glytec
- Change Healthcare
- MedCurrent Corporation
- Think Research Corporation
- Telus Health
- Grand River Hospital
- MedChart
- WELL Health Technologies
- Koninklijke Philips NV
- Slashdot
- ForeSee Medical
- Frost & Sullivan
- Lippincott
- Dedalus Group
- Vezeeta
- Wolters Kluwer Health
- Medisys HealthTec
- OpenMRS
- PATH
- McKesson
- FHI Clinical Inc
- Triclinium Clinical Development (TCD)
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 333 |
| Published | June 2025 |
| Forecast Period | 2024 - 2034 |
| Estimated Market Value ( USD | $ 3.14 Billion |
| Forecasted Market Value ( USD | $ 10.74 Billion |
| Compound Annual Growth Rate | 13.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 53 |
